COVID-19: Caring for Patients and Communities

Dec 17, 2020
Please join AHA Board Chair Melinda Estes, M.D., for the eleventh in a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. Dr. Estes was joined by Rodney F. Hochman, M.D., President and CEO,…
Dec 16, 2020
In a compelling video interview, four front-line health care professionals with Mayo Clinic shared their experiences caring for COVID-19 patients.
Dec 14, 2020
Combining the anti-inflammatory drug baricitinib with the antiviral drug remdesivir reduced the median recovery time for hospitalized COVID-19 patients from eight to seven days, according to clinical trial results published in the New England Journal of Medicine.
Dec 11, 2020
Benjamin Franklin said “energy and persistence conquers all things.” Those words are certainly appropriate for this year as we continue our battle against COVID-19. They also are very pertinent for the next week as we must keep the pressure on Congress to make sure they provide hospitals and health…
Dec 3, 2020
Please join AHA Board Chair Melinda Estes, M.D., for the tenth in a series of Leadership Rounds. Dr. Estes is joined by Claire Zangerle, MSN, MBA, RN, Chief Nurse Executive at Allegheny Health Network (AHN), to discuss how hospitals can move from relief, recovery, and rebuilding to reimagining and…
Dec 1, 2020
In an open letter to the American public, the AHA, along with the American Medical Association and American Nurses Association, today affirmed their support for vaccines as a critical means for protecting individuals, communities and loved ones from COVID-19, the worst global health crisis in…
Nov 30, 2020
Effective Feb. 1, physicians and other health care providers and suppliers should use new National Uniform Billing Committee condition codes on claims for COVID-19 and other treatments authorized by the Food and Drug Administration for emergency use or expanded access, the Centers for Medicare…
Nov 25, 2020
Over the next several months, the National Institute of Allergy and Infectious Diseases expects to enroll up to 1,500 adult COVID-19 hospital patients who require supplemental oxygen in a global clinical trial that aims to determine whether baricitinib or dexamethasone is more effective at…
Nov 23, 2020
The National Institutes of Health has awarded about $45 million to expand the research network for its Rapid Acceleration of Diagnostics Underserved Populations program.
Nov 23, 2020
The Department of Health and Human Services seeks information on innovative approaches and best practices developed to promote health care access, quality and value during the COVID-19 pandemic to inform the agency’s priorities and programs.